Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/24 21:45 | 9/6/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Beaver Sandra | CA | O | CFO | 6 | S | -236 | 12.71 | 0 | -19 | 160 | D | |||||||||||||||
9/4/24 16:14 | 8/30/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Yamagishi-Dressler Tomoko | CA | O | CMO | 1 | S | -89 | 15.85 | 0 | -6 | 82 | D | |||||||||||||||
6/6/24 19:01 | 6/4/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Moatazedi David | CA | DO | See Rema | 7 | S.dm | -8,716 | 12.53 | 0 | -695 | 792 | D | |||||||||||||||
6/5/24 21:30 | 6/3/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Malik Vikram | CA | D | 2 | S | -459 | 12.94 | 0 | -36 | 254 | D | ||||||||||||||||
5/15/24 17:20 | 5/13/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Gill David N | CA | D | 1 | S.m | -131 | 12.64 | 0 | -10 | 34 | D | ||||||||||||||||
5/14/24 20:56 | 5/10/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Avelar Rui | CA | O | See Rema | 4 | S | -475 | 13.53 | 0 | -35 | 400 | D | |||||||||||||||
2/2/24 16:57 | 1/30/24 | EOLS | Health | Drug | Pharmaceutical Preparations | Parschauer Karah Herdman | CA | D | 1 | S | -157 | 13.14 | 0 | -12 | 31 | D | ||||||||||||||||
10/18/23 16:21 | 10/16/23 | EOLS | Health | Drug | Pharmaceutical Preparations | Medytox Inc. | M5 | H | Former 1 | 1 | S | -12,680 | 7.50 | 0 | -1,691 | 3,381 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |